Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Translational Development Acquisition PB Ratio Related Terms
Translational Development Acquisition PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Translational Development Acquisition PB Ratio Chart
Translational Development Acquisition Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
PB Ratio
0.00
0.00
0.00
1.31
Translational Development Acquisition Quarterly Data
For the Shell Companies subindustry, Translational Development Acquisition's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Translational Development Acquisition PB Ratio vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Translational Development Acquisition's PB Ratio distribution charts can be found below:
* The bar in red indicates where Translational Development Acquisition's PB Ratio falls into.
Translational Development Acquisition PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Translational Development Acquisition (TDAC) has a PB Ratio of 1.34 as of Jul. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Translational Development Acquisition and its competitors. According to the industry distribution chart, Translational Development Acquisition ranks #201 out of 462 companies in the Diversified Financial Services industry, placing it in the top 43.5%.
Is Translational Development Acquisition's PB Ratio too high?
Translational Development Acquisition's current PB Ratio is 1.34. The Diversified Financial Services industry median PB Ratio is 1.39. Translational Development Acquisition's value of 1.34 is 3.6% below this industry median. Based on the distribution chart, Translational Development Acquisition ranks #201 out of 462 companies in the Diversified Financial Services industry, which is above the industry midpoint. Overall, Translational Development Acquisition has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Translational Development Acquisition's PB Ratio compare to WLII and AESP?
According to the Diversified Financial Services industry distribution chart, Translational Development Acquisition ranks #201 out of 462 companies for PB Ratio. This puts Translational Development Acquisition in the upper half of its industry. The industry median PB Ratio is 1.39. Translational Development Acquisition's value of 1.34 is 3.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Diversified Financial Services company?
The median PB Ratio among Diversified Financial Services companies is 1.39, based on 462 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Translational Development Acquisition's current PB Ratio of 1.34 is 3.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Translational Development Acquisition and its competitors. For the Diversified Financial Services industry, the median PB Ratio is 1.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Translational Development Acquisition's current PB Ratio is 1.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Translational Development Acquisition stock overvalued right now?
Translational Development Acquisition (TDAC) has a current PB Ratio of 1.34. The current PB Ratio is 1.34 and 3.6% below the Diversified Financial Services industry median of 1.39. Translational Development Acquisition's overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Translational Development Acquisition (TDAC), the current PB Ratio is 1.34 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Translational Development Acquisition Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TDAC has been successfully added to your 
